182 related articles for article (PubMed ID: 20798498)
1. Phosphoglycerate kinase 1 promoting tumor progression and metastasis in gastric cancer - detected in a tumor mouse model using positron emission tomography/magnetic resonance imaging.
Zieker D; Königsrainer I; Weinreich J; Beckert S; Glatzle J; Nieselt K; Bühler S; Löffler M; Gaedcke J; Northoff H; Mannheim JG; Wiehr S; Pichler BJ; von Weyhern C; Brücher BL; Königsrainer A
Cell Physiol Biochem; 2010; 26(2):147-54. PubMed ID: 20798498
[TBL] [Abstract][Full Text] [Related]
2. Phosphoglycerate kinase 1 a promoting enzyme for peritoneal dissemination in gastric cancer.
Zieker D; Königsrainer I; Tritschler I; Löffler M; Beckert S; Traub F; Nieselt K; Bühler S; Weller M; Gaedcke J; Taichman RS; Northoff H; Brücher BL; Königsrainer A
Int J Cancer; 2010 Mar; 126(6):1513-20. PubMed ID: 19688824
[TBL] [Abstract][Full Text] [Related]
3. shRNA-mediated inhibition of PhosphoGlycerate Kinase 1 (PGK1) enhances cytotoxicity of intraperitoneal chemotherapy in peritoneal metastasis of gastric origin.
Archid R; Zieker D; Weinreich FJ; Hönes F; Königsrainer A; Quintanilla-Martínez L; Reymond MA; Solass W
Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):613-619. PubMed ID: 31980221
[TBL] [Abstract][Full Text] [Related]
4. PGK1 a potential marker for peritoneal dissemination in gastric cancer.
Zieker D; Königsrainer I; Traub F; Nieselt K; Knapp B; Schillinger C; Stirnkorb C; Fend F; Northoff H; Kupka S; Brücher BL; Königsrainer A
Cell Physiol Biochem; 2008; 21(5-6):429-36. PubMed ID: 18453750
[TBL] [Abstract][Full Text] [Related]
5. Induction of tumor stem cell differentiation--novel strategy to overcome therapy resistance in gastric cancer.
Zieker D; Bühler S; Ustündag Z; Königsrainer I; Manncke S; Bajaeifer K; Vollmer J; Fend F; Northoff H; Königsrainer A; Glatzle J
Langenbecks Arch Surg; 2013 Apr; 398(4):603-8. PubMed ID: 23412594
[TBL] [Abstract][Full Text] [Related]
6. Phosphoglycerate kinase 1 as a promoter of metastasis in colon cancer.
Ahmad SS; Glatzle J; Bajaeifer K; Bühler S; Lehmann T; Königsrainer I; Vollmer JP; Sipos B; Ahmad SS; Northoff H; Königsrainer A; Zieker D
Int J Oncol; 2013 Aug; 43(2):586-90. PubMed ID: 23727790
[TBL] [Abstract][Full Text] [Related]
7. RNA Binding Protein PTBP1 Promotes the Metastasis of Gastric Cancer by Stabilizing
Wang X; Liang C; Wang S; Ma Q; Pan X; Ran A; Qin C; Huang B; Yang F; Liu Y; Zhang Y; Ren J; Ning H; Li H; Jiang Y; Xiao B
Cells; 2024 Jan; 13(2):. PubMed ID: 38247832
[TBL] [Abstract][Full Text] [Related]
8. Phosphoglycerate kinase 1 (PGK1) in cancer: A promising target for diagnosis and therapy.
Fu Q; Yu Z
Life Sci; 2020 Sep; 256():117863. PubMed ID: 32479953
[TBL] [Abstract][Full Text] [Related]
9. Metabolic alteration--Overcoming therapy resistance in gastric cancer via PGK-1 inhibition in a combined therapy with standard chemotherapeutics.
Schneider CC; Archid R; Fischer N; Bühler S; Venturelli S; Berger A; Burkard M; Kirschniak A; Bachmann R; Königsrainer A; Glatzle J; Zieker D
Int J Surg; 2015 Oct; 22():92-8. PubMed ID: 26298000
[TBL] [Abstract][Full Text] [Related]
10. An orthotopic model of pancreatic somatostatin receptor (SSTR)-positive tumors allows bimodal imaging studies using 3T MRI and animal PET-based molecular imaging of SSTR expression.
Stelter L; Amthauer H; Rexin A; Pinkernelle J; Schulz P; Michel R; Denecke T; Stiepani H; Hamm B; Wiedenmann B; Scholz A
Neuroendocrinology; 2008; 87(4):233-42. PubMed ID: 18025811
[TBL] [Abstract][Full Text] [Related]
11. PGK1 Drives Hepatocellular Carcinoma Metastasis by Enhancing Metabolic Process.
Xie H; Tong G; Zhang Y; Liang S; Tang K; Yang Q
Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28749413
[TBL] [Abstract][Full Text] [Related]
12. Macrophage-Associated PGK1 Phosphorylation Promotes Aerobic Glycolysis and Tumorigenesis.
Zhang Y; Yu G; Chu H; Wang X; Xiong L; Cai G; Liu R; Gao H; Tao B; Li W; Li G; Liang J; Yang W
Mol Cell; 2018 Jul; 71(2):201-215.e7. PubMed ID: 30029001
[TBL] [Abstract][Full Text] [Related]
13. Associations of PGK1 promoter hypomethylation and PGK1-mediated PDHK1 phosphorylation with cancer stage and prognosis: a TCGA pan-cancer analysis.
Shao F; Yang X; Wang W; Wang J; Guo W; Feng X; Shi S; Xue Q; Gao S; Gao Y; Lu Z; He J
Cancer Commun (Lond); 2019 Oct; 39(1):54. PubMed ID: 31578148
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of phosphoglycerate kinase 1 by shRNA sensitizes U251 xenografts to radiotherapy.
Cheng YJ; Ding H; Du HQ; Yan H; Zhao JB; Zhang WB; Zou YJ; Liu HY; Xiao H
Oncol Rep; 2014 Oct; 32(4):1513-20. PubMed ID: 25175369
[TBL] [Abstract][Full Text] [Related]
15. FOXO3A-induced LINC00926 suppresses breast tumor growth and metastasis through inhibition of PGK1-mediated Warburg effect.
Chu Z; Huo N; Zhu X; Liu H; Cong R; Ma L; Kang X; Xue C; Li J; Li Q; You H; Zhang Q; Xu X
Mol Ther; 2021 Sep; 29(9):2737-2753. PubMed ID: 33940159
[TBL] [Abstract][Full Text] [Related]
16. PGK1 is a Potential Survival Biomarker and Invasion Promoter by Regulating the HIF-1α-Mediated Epithelial-Mesenchymal Transition Process in Breast Cancer.
Fu D; He C; Wei J; Zhang Z; Luo Y; Tan H; Ren C
Cell Physiol Biochem; 2018; 51(5):2434-2444. PubMed ID: 30537744
[TBL] [Abstract][Full Text] [Related]
17. Expression of PGK1 by prostate cancer cells induces bone formation.
Jung Y; Shiozawa Y; Wang J; Wang J; Wang Z; Pedersen EA; Lee CH; Hall CL; Hogg PJ; Krebsbach PH; Keller ET; Taichman RS
Mol Cancer Res; 2009 Oct; 7(10):1595-604. PubMed ID: 19825988
[TBL] [Abstract][Full Text] [Related]
18. [Highly metastatic nude mouse model of human primary gastric lymphoma constructed by surgical orthotopic transplantation and in vivo continuous screening method].
Yang B; Tuo S; Tuo CW; Zhang N; Liu QZ
Zhonghua Yi Xue Za Zhi; 2010 Feb; 90(6):413-7. PubMed ID: 20367942
[TBL] [Abstract][Full Text] [Related]
19. [Expression of phosphoglycerate kinase 1 in endometrial carcinoma and its association with patients' outcome].
Lin L; Jiang QP; Lin D; Chen W; Jiang HP; Liu CH; Xiao YY; Zhu LT; Guo SQ
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Apr; 38(4):471-476. PubMed ID: 29735450
[TBL] [Abstract][Full Text] [Related]
20. Phosphoglycerate kinase-1 is a predictor of poor survival and a novel prognostic biomarker of chemoresistance to paclitaxel treatment in breast cancer.
Sun S; Liang X; Zhang X; Liu T; Shi Q; Song Y; Jiang Y; Wu H; Jiang Y; Lu X; Pang D
Br J Cancer; 2015 Apr; 112(8):1332-9. PubMed ID: 25867275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
